Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aurora Cannabis Inc. (ACB) vs BioAge Labs, Inc. (BIOA)

Aurora Cannabis Inc. and BioAge Labs, Inc. are both Drug Manufacturers Specialty & Generic companies. BioAge Labs, Inc. is the larger, with a market value of $337.4M against $267.8M — 1.3× the size. Aurora Cannabis Inc. has the higher net margin (−38.1% vs −912.3%) and the higher return on invested capital (−5.58% vs −118.3%). Across the 16 metrics below, Aurora Cannabis Inc. leads on 9 and BioAge Labs, Inc. on 7.

Valuation

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.20 30.53 2.25
P/B 0.66 0.84 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.00 12.29
EV/Sales 0.96 (0.04) 2.56
Earnings yield (34.39%) (33.76%) (2.99%)
Free cash flow yield (14.28%) (76.82%) 0.00%

Profitability

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 100.00% 53.94%
Operating margin (12.13%) (1,026.28%) 0.00%
Net margin (38.12%) (912.25%) 0.00%
Free cash flow margin (17.19%) (2,345.11%) 0.00%
Return on equity (19.85%) (28.21%) (0.40%)
Return on assets (15.19%) (26.27%) (3.32%)
Return on invested capital (5.58%) (118.25%) 0.00%

Growth

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) — 10.01%
EPS growth (last fiscal year) (5,266.67%) 66.21% —
Revenue growth, 5-year CAGR 3.92% — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.00 0.05
Current ratio 5.36 17.19 2.31
Net debt to EBITDA 5.11 3.01 0.85

Dividend

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 — 0.00

Size

Metric ACB BIOA Drug Manufacturers Specialty & Generic median
Market cap 267.79m 337.35m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack